5 Einträge gefunden

1. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

   1. Alchalby, Haefaa
   2. Yunus, Dinah-Rohina
   3. Zabelina, Tatjana
   4. Kobbe, Guido
   5. Holler, Ernst
   6. Bornhäuser, Martin
   7. Schwerdtfeger, Rainer

   2012 - Forschungsinformationssystem des UKE
2. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

   1. Ayuketang Ayuk, Francis
   2. Perez-Simon, José A
   3. Shimoni, Avichai
   4. Sureda, Anna
   5. Zabelina, Tatjana
   6. Schwerdtfeger, Rainer
   7. Martino, Rodrigo

   2008 - Forschungsinformationssystem des UKE - frei zugänglich
3. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Shaw, Bronwen
   3. Iacobelli, Simona
   4. Zabelina, Tatjana
   5. Peggs, Karl
   6. Shimoni, Avichai
   7. Nagler, Arnon

   2005 - Forschungsinformationssystem des UKE
4. Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.

   1. Kröger, Nicolaus-Martin
   2. Schwerdtfeger, Rainer
   3. Kiehl, Michael
   4. Sayer, Herbert Gottfried
   5. Renges, Helmut-Hans
   6. Zabelina, Tatjana
   7. Fehse, Boris

   2002 - Forschungsinformationssystem des UKE
5. Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.

   1. Kröger, Nicolaus
   2. Sayer, Herbert Gottfried
   3. Schwerdtfeger, Rainer
   4. Kiehl, Michael
   5. Nagler, Arnon
   6. Renges, Helmut
   7. Zabelina, Tatjana

   2002 - Forschungsinformationssystem des UKE